InsidersTradesSigma
Track the 메디안디노스틱 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 메디안디노스틱 has recorded 14 public disclosures. The latest transaction was reported on 9 January 2025 (Purchase). Among the most active insiders: 나노헬릭스. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
14 of 14 declarations
Median Diagnostics is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative medical diagnostics.